Be Wary of the Techno-Fix
By Marcy Darnovsky,
Boston Review
| 11. 19. 2018
In Merve Emre’s essay "All Reproduction is Assisted," her commitment to the emancipatory power of reproductive technologies is untroubled by her own accounts of unsatisfactory endings. Perhaps she assumes that one day soon, when the technologies improve, they will set us free.
In her essay, Merve Emre declares that “all reproduction . . . is assisted.” Few feminists of any wave or stripe would disagree. But if the statement that none of us go it alone is solid, some of Emre’s other moves put her on shaky ground. In her opening volleys, she skips lightly across fifty years of feminist thinking about reproductive technologies, leaping from Shulamith Firestone to Adrienne Rich to xenofeminism, with a brief stop at Donna Haraway’s “A Cyborg Manifesto” (1984). She arrives at a diagnosis of contemporary reproductive culture: it is infected, she says, by “the discourse of the natural.” She takes contemporary feminism to task for this state of affairs, suggesting that it has not been sufficiently enthusiastic about high-tech reproduction and asserting that it “has not done a good enough job articulating what alternate strategies of reproduction may be.”
Is that really a fair critique of feminism today? Most feminists have long been aware that simplistic appeals to nature can justify anything, including gender inequalities and oppression. And while questions about “nature” and “technology” are very...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...